J1330 – Injection, ergonovine maleate, up to 0.2 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1330
- Long description
- Injection, ergonovine maleate, up to 0.2 mg
- Short description
- Ergonovine maleate injection
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 1, 1986
- Last change
- January 1, 2026 – No change
- Termination date
- December 31, 2025
Frequently asked questions
What is HCPCS code J1330?
J1330 is a HCPCS Level II code for injection, ergonovine maleate, up to 0.2 mg. It was discontinued on December 31, 2025.
Does Medicare cover J1330?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1308 – Injection, famotidine, 0.25 mg
- J1320 – Injection, amitriptyline hcl, up to 20 mg
- J1322 – Injection, elosulfase alfa, 1 mg
- J1323 – Injection, elranatamab-bcmm, 1 mg
- J1324 – Injection, enfuvirtide, 1 mg
- J1325 – Injection, epoprostenol, 0.5 mg
- J1326 – Injection, zolbetuximab-clzb, 2 mg
- J1327 – Injection, eptifibatide, 5 mg
- J1335 – Injection, ertapenem sodium, 500 mg
- J1364 – Injection, erythromycin lactobionate, per 500 mg
- J1370 – Injection, esomeprazole sodium, 1 mg
- J1380 – Injection, estradiol valerate, up to 10 mg
- J1410 – Injection, estrogen conjugated, per 25 mg
- J1411 – Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 – Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1413 – Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.